Stereotaxis, Inc. financial data

Symbol
STXS on NYSE
Industry
Electromedical & Electrotherapeutic Apparatus
Location
710 N Tucker Blvd, Ste 110, St.Louis, MO
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2024 - Aug 14, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 249 % -13.8%
Quick Ratio 63.7 % +15.6%
Debt-to-equity 129 % +47.6%
Return On Equity -136 % -74.2%
Return On Assets -51.3 % -37.9%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 84.7M shares +4.68%
Entity Public Float 101M USD -8.85%
Common Stock, Value, Issued 83K USD +2.47%
Weighted Average Number of Shares Outstanding, Basic 84.6M shares +4.35%
Weighted Average Number of Shares Outstanding, Diluted 84.6M shares +4.35%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 23.7M USD -19.1%
Cost of Revenue 9.67M USD -22.2%
Research and Development Expense 9.4M USD -11.5%
Selling and Marketing Expense 12.2M USD -3.15%
General and Administrative Expense 14.2M USD +0.38%
Operating Income (Loss) -21.7M USD -6.4%
Net Income (Loss) Attributable to Parent -20.7M USD -7.09%
Earnings Per Share, Basic -0.26 USD/shares +3.7%
Earnings Per Share, Diluted -0.26 USD/shares +3.7%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 14.7M USD -35.8%
Accounts Receivable, after Allowance for Credit Loss, Current 2.78M USD -58.1%
Inventory, Net 9.28M USD +20.5%
Assets, Current 28.1M USD -27.8%
Property, Plant and Equipment, Net 3.06M USD -14.8%
Operating Lease, Right-of-Use Asset 4.77M USD -8.12%
Assets 36M USD -25.5%
Accounts Payable, Current 4.15M USD +46%
Accrued Liabilities, Current 2.7M USD -7.6%
Contract with Customer, Liability, Current 4.95M USD -39.8%
Liabilities, Current 12.3M USD -14.8%
Contract with Customer, Liability, Noncurrent 2.12M USD +29.4%
Operating Lease, Liability, Noncurrent 4.82M USD -8.69%
Other Liabilities, Noncurrent 54K USD +25.6%
Liabilities 19.3M USD -9.82%
Retained Earnings (Accumulated Deficit) -548M USD -3.94%
Stockholders' Equity Attributable to Parent 11.4M USD -46.9%
Liabilities and Equity 36M USD -25.5%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -2.35M USD +16.3%
Net Cash Provided by (Used in) Financing Activities 30K USD -46.4%
Net Cash Provided by (Used in) Investing Activities -349K USD +69.8%
Common Stock, Shares Authorized 300M shares 0%
Common Stock, Shares, Issued 83M shares +2.86%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -2.32M USD +25.2%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 15.2M USD -36.6%
Deferred Tax Assets, Valuation Allowance 35.1M USD +8.96%
Deferred Tax Assets, Gross 36.3M USD +8.43%
Operating Lease, Liability 5.28M USD -7.04%
Depreciation 140K USD -12.5%
Lessee, Operating Lease, Liability, to be Paid 7.29M USD -10.9%
Property, Plant and Equipment, Gross 7.2M USD +0.24%
Operating Lease, Liability, Current 458K USD +14.8%
Lessee, Operating Lease, Liability, to be Paid, Year Two 935K USD +1.74%
Lessee, Operating Lease, Liability, to be Paid, Year One 919K USD +2.34%
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 2.01M USD -19.6%
Lessee, Operating Lease, Liability, to be Paid, Year Three 956K USD +2.25%
Deferred Tax Assets, Operating Loss Carryforwards 29.1M USD +5.39%
Preferred Stock, Shares Authorized 10M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 976K USD +2.09%
Operating Lease, Payments 1.02M USD +6.78%
Additional Paid in Capital 559M USD +1.95%
Preferred Stock, Shares Outstanding 5.61M shares 0%
Deferred Tax Assets, Net of Valuation Allowance 1.23M USD -4.57%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%